Yukichi Tokita

Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial

Wataru Shimizu, Yoshiaki Kubota, Yu Hoshika et al. · Cardiovascular Diabetology · 2020 · 232 citations · Full text

Medicine, Cardiology, Pharmacology +17

Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration

Yukichi Tokita, Xian‐Liang Tang, Qianhong Li et al. · Circulation Research · 2016 · 123 citations · Full text

Medicine, Cardiology, Pharmacology +13

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 122 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 94 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Massive Pulmonary Embolism Requiring Extracorporeal Life Support Treated With Catheter-Based Interventions

Ryo Munakata, Takeshi Yamamoto, Yusuke Hosokawa et al. · International Heart Journal · 2012 · 68 citations · Full text

Medicine, Cardiology, Surgery +15